Sector valuations RaySearch Laboratories AB
Stocks
RAY B
SE0000135485
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 177.90 SEK | +2.01% |
|
-23.25% | -21.97% |
| 07-17 | Affarsvarlden issues a neutral recommendation for Raysearch after the profit warning | FW |
| 07-16 | RaySearch Laboratories AB Provides Earnings Guidance for the Second Quarter of 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 21.09x | 6.61x | 0.87x | 4.35x | 9.39x | 17.38x | 2.29% | 620M | ||
| 30.55x | 3.9x | 1.74x | 6.73x | 14.9x | 15.2x | -.--% | 31.74B | ||
| 86.17x | 48.33x | 0.89x | 73.83x | 91.96x | 95.4x | 0.43% | 13.65B | ||
| 80.86x | 20.4x | 5.01x | 11.92x | 51.75x | 59.89x | 0.72% | 5.5B | ||
| -31.23x | 8.04x | 0.42x | 8.76x | -47.4x | -41.07x | - | 2.15B | ||
| 58.81x | - | 0.03x | - | - | - | -.--% | 2.09B | ||
| -5.93x | - | 0.11x | 58.59x | -5.93x | -5.5x | - | 1.74B | ||
| 6.2x | - | -0.01x | - | - | - | - | 901M | ||
| 110.67x | 1.3x | -0.99x | - | - | - | 1.2% | 759M | ||
| -70.19x | 90.91x | 8.09x | 910.47x | -84.99x | -73.89x | -.--% | 692M | ||
| -7.97x | 1.84x | 0.09x | 0.6x | 11.97x | 17.4x | 1.82% | 654M | ||
| -14.84x | - | 0.17x | -0.41x | -2.96x | -6.99x | -.--% | 518M | ||
| -6.47x | - | 0.29x | - | - | - | - | 492M | ||
| 43.4x | - | -0.38x | - | - | - | - | 369M | ||
| -28.36x | 1.88x | 0.42x | - | - | - | - | 340M | ||
| 34.04x | - | 0.31x | 2.49x | 9.46x | 9.98x | - | 321M | ||
| -15.21x | - | -0.27x | - | - | - | - | 201M | ||
| -13.54x | 3.12x | 2x | 2.69x | 301.36x | -12.99x | - | 183M | ||
| Average | 15.45x | 18.63x | 1.04x | 98.18x | 31.77x | 6.80x | 0.72% | 3.49B | |
| Weighted average by Cap. | 42.69x | 17.47x | 1.62x | 35.35x | 33.11x | 34.36x | 0.24% |
- Stock Market
- Stocks
- RAY B Stock
- Sector RaySearch Laboratories AB
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















